Financhill
Back

Becton Dickinson & Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
46

BDX
Becton Dickinson &

Last Price:
233.86
Seasonality Move:
0.03%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
46
Becton Dickinson & (BDX) is a Sell

Is Becton Dickinson & a Buy, Sell or Hold?

  • The current Becton Dickinson & [BDX] share price is $233.87. The Score for BDX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.39. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BDX Stock Price Chart

What is Becton Dickinson &'s stock price today?

  • The Becton Dickinson & share price today is $233.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDX is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.39
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

BDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.2 Buy
Relative Strength Index (14 RSI): 47.65 Sell
Chaikin Money Flow: -297429 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (230.09 - 238.53) Sell
Bollinger Bands (100): (232.94 - 242) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.74 Sell
Relative Strength Index (14 RSI): 45.16 Sell
Chaikin Money Flow: -377368 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

BDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 234.83 Sell
20-day SMA: 234.61 Sell
50-day SMA: 234.48 Sell
200-day SMA: 242.52 Sell
8-day EMA: 235.43 Sell
20-day EMA: 235.17 Sell
50-day EMA: 235.6 Sell
200-day EMA: 241.54 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.13 Sell
20-day SMA: 40.38 Sell
50-day SMA: 41.72 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.68 Sell
20-day EMA: 40.43 Sell
50-day EMA: 41.92 Sell
200-day EMA: 43.42 Sell

Becton Dickinson & Earnings Growth & BDX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.66 per share, an increase next quarter of $0.54 per share, an increase this year of $0.89 per share, and an increase next year of $1.23 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Becton Dickinson & Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):